Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1990-3-1
|
pubmed:abstractText |
Newly diagnosed, previously untreated patients with type 2 diabetes mellitus (n = 6) were studied on two separate days after overnight fasts. On each day they were given a 500-kcal mixed meal plus an infusion of either porcine glucose-dependent insulinotropic polypeptide (GIP) (0.75 pmol/kg/min) or control solution (CS) from 0 to 30 min in random order. Frequent measurements of plasma glucose, C-peptide, insulin and GIP concentrations were made. Fasting GIP levels were similar on both days. During the meal plus GIP infusion plasma GIP levels increased from a basal value of 7.6 +/- 1.5 pmol/1 to a peak of 88.6 +/- 5.4 pmol/1 at 30 min. Following the meal infusion of CS GIP increased from a fasting level of 10.3 +/- 1.2 pmol/1 to a significantly lower peak of 58.0 +/- 8.3 pmol/1 at 60 min. During the meal plus GIP infusion GIP levels were higher at 10-45 min and at 90 min (P less than 0.05-0.001). Fasting and postprandial glucose, C-peptide and insulin levels were, however, similar on both study day. A supplementary infusion of porcine GIP with a mixed meal did not significantly alter the beta cell response or glucose tolerance in this group of patients with type 2 diabetes mellitus.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0168-8227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
263-9
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2693029-Animals,
pubmed-meshheading:2693029-Blood Glucose,
pubmed-meshheading:2693029-C-Peptide,
pubmed-meshheading:2693029-Diabetes Mellitus, Type 2,
pubmed-meshheading:2693029-Eating,
pubmed-meshheading:2693029-Energy Intake,
pubmed-meshheading:2693029-Fasting,
pubmed-meshheading:2693029-Gastric Inhibitory Polypeptide,
pubmed-meshheading:2693029-Humans,
pubmed-meshheading:2693029-Insulin,
pubmed-meshheading:2693029-Islets of Langerhans,
pubmed-meshheading:2693029-Male,
pubmed-meshheading:2693029-Middle Aged,
pubmed-meshheading:2693029-Random Allocation,
pubmed-meshheading:2693029-Swine
|
pubmed:year |
1989
|
pubmed:articleTitle |
A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
|
pubmed:affiliation |
Department of Medicine, University of Wales, Cardiff, U.K.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|